Shares in Senseonics (NYSE:SENS) fell today even though the medical technology company beat expectations on Wall Street with its third quarter results. The Germantown, Md.-based company posted a loss of -$17.4 million on sales of $2.1 million for the 3 months ended Sept. 30. Get the full story at our sister site, Drug Delivery Business News.
MassDevice Earnings Roundup
Novo Nordisk shares slip on cautious guidance, insulin pricing concerns
Shares in Novo Nordisk (NYSE:NVO) fell slightly today after the insulin-maker met expectations on Wall Street with its third quarter results, but issued cautious sales guidance for 2018. The company’s chief executive expressed concerns that draft legislation to make drug pricing more transparent could potentially hurt the industry, according to Reuters. Get the full story at our sister […]
Owens & Minor to buy Halyard Health’s infection prevention biz for $710m
Owens & Minor (NYSE:OMI) agreed to pay $710 million to acquire Halyard Health‘s (NYSE:HYH) surgical and infection prevention business. The deal, expected to close during the first quarter next year, adds $1 billion in revenues and $80 million in earnings before interest, taxes, depreciation & amortization to Owen’s & Minor’s books annually. “Halyard’s S&IP business […]
Zimmer Biomet misses the mark with Q3 results
Zimmer Biomet (NYSE:ZBH) missed the mark with its third-quarter results as ongoing supply issues plagued the orthopedics giant. Warsaw, Ind.-based Zimmer Biomet posted profits of $98.8 million, or 48¢ per share, on sales of $1.82 billion for the three months ended Sept. 30, for a bottom-line slide of -37.8% and a sales decline of -0.8% compared […]
Pfizer posts Street-beating Q3, raises full-year earnings forecast
Shares in Pfizer (NYSE:PFE) fell slightly today even though the pharmaceutical giant beat expectations on Wall Street with its third quarter results. The New York-based company posted profits of $2.84 billion, or 47¢ per share, on sales of $13.17 billion, for sales growth of 1% compared with last year’s third quarter results. Get the full story at […]
Orthofix’s Q3 profits plunge
Third-quarter profits for Orthofix (NSDQ:OFIX) plunged some 65% compared with the same period last year on increased income tax expenses, but the orthopedics company raised its 2017 sales outlook and increased the high end of its earnings forecast. Lewisville, Texas-based Orthofix posted profits of $3.5 million, or 19¢ per share, on sales of $105.2 million for […]
Align Technology shares soar on solid Q3 beat
Shares in Align Technology (NSDQ:ALGN) have risen over 15% today after the orthodontic device maker beat expectations on Wall Street with its third quarter results. The San Jose, Calif.-based company posted profits of $82.6 million, or $1.01 per share, on sales of $385.3 million for the 3 months ended September 30, for bottom-line growth of 60.7% […]
Merit Medical slides to Q3 red on acquisition expenses
Expenses from recent acquisitions pushed Merit Medical (NSDQ:MMSI) into the red during the third quarter, but the medical device maker still managed to top Wall Street’s earnings forecast for the quarter. CEO Fred Lampropoulos said Merit acquired bone biopsy assets from Laurane Medical; spinal implant maker Osseon; steerable “smart” guidewire maker IntelliMedical Technologies; and ITL Healthcare and its custom […]
Tandem reels in losses but misses revenue estimates in Q3
Shares in Tandem Diabetes Care (NSDQ:TNDM) rose today after the medical device maker reeled in its losses but missed sales estimates on Wall Street with its third quarter results. The San Diego, Calif.-based company posted losses of -$16 million on sales of $23.7 million for the 3 months ended Sept. 30, for bottom-line growth of 46% on […]
Merck raises full-year guidance despite mixed Q3
Shares in Merck (NYSE:MRK) slipped in pre-market activity today after the pharmaceutical company beat earnings estimates but missed sales expectations on Wall Street with its third quarter results. The Kenilworth, N.J.-based company posted a loss of -$51 million, or -2¢ per share, on sales of $10.33 billion for the 3 months ended Sept. 30. Get the full […]
ResMed lifts on FY2018 Q1 sales beat
Shares in ResMed (NYSE:RMD) have risen in after-hours trading after the medical device maker beat expectations on Wall Street with its 1st quarter fiscal year 2018 earnings results. The San Diego, Calif.-based company posted profits of $86.1 million, or 60¢ per share, on sales of $523.7 million for the 3 months ended September 30, seeing the […]